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Background
Colorectal cancer (CRC) is the most common cancer in
China. The incidence of CRC is increasing rapidly. The
early detection and early diagnosis is the effective way
to decreasing the mortality and increasing the survival
rate.
Materials and methods
From 2007, a CRC screening program was begun in three
cities (Hangzhou, Haerbing, and Shanghai city, aimed at
finding more early CRC cases and premalignant lesions
such as adenoma. The two steps screening model was
applied. As the primary screening, the Simultaneous
iFOBT (immunochemical Fecal Occult Blood Testing) and
high risk factors questionnaire investigation (HRFQ) will
be employed for selection the high risk population from
target population. Then the high risk population will be
further selected by colonoscopy.
Results
The compliance of the two steps screening model was
only 34.88% (1650/ 4730) in city target. The overall posi-
tive rate in the first screening stage was 13.5% (4,730 of
35,037). In the second stage, the positive rate of total col-
orectal neoplasm was 27.27% (450/1650) in the total
study population. The detected ratesof cancer, adenoma,
non-adenomatous polyps, and advanced neoplasm were
13%.
Conclusions
The combining iFOBT and HRFQ as primary screening
methods is an efficient CRC screening strategy in econom-
ically and medically underserved population. But the novel
early CRC markers were still needed to improve the
compliance of the screening program.
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